BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 28266708)

  • 1. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
    Rahmani F; Avan A; Hashemy SI; Hassanian SM
    J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer.
    Soleimani A; Rahmani F; Saeedi N; Ghaffarian R; Khazaei M; Ferns GA; Avan A; Hassanian SM
    J Cell Biochem; 2019 Dec; 120(12):19245-19253. PubMed ID: 31512778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
    Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
    Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
    Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T
    Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-Wnt signaling regulatory network in colorectal cancer.
    Jafarzadeh M; Soltani BM
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22883. PubMed ID: 34382723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
    Rahmani F; Tadayyon Tabrizi A; Hashemian P; Alijannejad S; Rahdar HA; Ferns GA; Hassanian SM; Shahidsales S; Avan A
    Gene; 2020 Sep; 754():144892. PubMed ID: 32534060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma.
    Fasihi A; M Soltani B; Atashi A; Nasiri S
    J Cell Biochem; 2018 Jul; 119(7):5104-5117. PubMed ID: 28817181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review.
    Elrebehy MA; Al-Saeed S; Gamal S; El-Sayed A; Ahmed AA; Waheed O; Ismail A; El-Mahdy HA; Sallam AM; Doghish AS
    Int J Biol Macromol; 2022 Aug; 214():583-600. PubMed ID: 35768045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircRNA_100290 promotes colorectal cancer progression through miR-516b-induced downregulation of FZD4 expression and Wnt/β-catenin signaling.
    Fang G; Ye BL; Hu BR; Ruan XJ; Shi YX
    Biochem Biophys Res Commun; 2018 Sep; 504(1):184-189. PubMed ID: 30173892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
    Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
    Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
    Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-29b downregulates canonical Wnt signaling by suppressing coactivators of β-catenin in human colorectal cancer cells.
    Subramanian M; Rao SR; Thacker P; Chatterjee S; Karunagaran D
    J Cell Biochem; 2014 Nov; 115(11):1974-84. PubMed ID: 24913975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
    Kwak B; Kim DU; Kim TO; Kim HS; Kim SW
    Int J Oncol; 2018 Oct; 53(4):1800-1808. PubMed ID: 30066856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-185 is a novel tumor suppressor by negatively modulating the Wnt/β-catenin pathway in human colorectal cancer.
    Dong-Xu W; Jia L; Su-Juan Z
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E182-5. PubMed ID: 27453420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
    Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.